Blair James C

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Blair James C
CIK #0001024000
EDGAR Form CIK 2011 - 2026
3 [0001024000]
4 [0001024000]
Form 3/4/5 Subject 2011 - 2026
Blair James C
Clovis Oncology Inc
Vitullo Nicole
Treu Jesse I
Domain Parters VII L P
Dovey Brian H
Halak Brian K
Obalon Therapeutics Inc
DP VIII Associates LP
Adynxx Inc
Domain Partners VIII LP
aTYR Pharma Inc
Bionano Genomics Inc
Kamdar Kim P
Domain Associates
Dicerna Pharmaceuticals Inc
Tranzyme Inc
DP VI Associates LP
Domain Partners VI LP
Regado Biosciences Inc
DP VII Associates LP
CoLucid Pharmaceuticals Inc
Evoke Pharma Inc
Syndax Pharmaceuticals Inc
Shah Nimesh
Schoemaker Kathleen K
GLAUKOS Corp
Domain Partners IV LP
DP IV Associates LP
Esperion Therapeutics Inc
Evofem Biosciences Inc
Durata Therapeutics Inc
Atara Biotherapeutics Inc
Veracyte Inc
Otonomy Inc
Marinus Pharmaceuticals Inc
Zogenix Inc
Aldeyra Therapeutics Inc
Cadence Pharmaceuticals Inc
Achaogen Inc
Alimera Sciences Inc
Tandem Diabetes Care Inc
Achillion Pharmaceuticals Inc
Celator Pharmaceuticals Inc
REVA Medical Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
2021-06-10 Grant 42,223 $0.00
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
2020-06-04 Grant 40,138 $0.00
Clovis Oncology Inc CLVS
Common Stock
2019-08-20 Buy 20,000 $5.97 119,400
Clovis Oncology Inc CLVS
Common Stock
2019-08-16 Buy 20,000 $5.70 114,000
Obalon Therapeutics Inc OBLN
Common Stock
2019-08-06 Buy 250,000 $4.00 1,000,000
Obalon Therapeutics Inc OBLN
Warrants to Purchase Common Stock · derivative
2019-08-06 Buy 187,500 $4.00 750,000
Clovis Oncology Inc CLVS
Stock Option (Right to buy) · derivative
2019-06-06 Grant 28,882 $0.00
aTYR Pharma Inc LIFE
Stock Option (right to buy) · derivative
2019-05-08 Grant 20,000 $0.00
Clovis Oncology Inc CLVS
Common Stock
2019-03-18 Other 701 $0.00
Clovis Oncology Inc CLVS
Common Stock
2019-03-18 Other 522 $0.00
Clovis Oncology Inc CLVS
Common Stock
2019-03-18 Other 10,000 $0.00
Clovis Oncology Inc CLVS
Common Stock
2019-03-14 Sell 17,056 $27.79 473,986
Clovis Oncology Inc CLVS
Common Stock
2019-02-01 Other 10,000 $0.00
Clovis Oncology Inc CLVS
Common Stock
2019-02-01 Other 1,000,000 $0.00
Clovis Oncology Inc CLVS
Stock Option (Right to buy) · derivative
2018-10-11 Grant 14,770 $0.00
Bionano Genomics Inc BNGO
Series C Preferred Stock · derivative
2018-08-23 Conversion 5,426,808 $0.00
Bionano Genomics Inc BNGO
Series B-1 Preferred Stock · derivative
2018-08-23 Conversion 2,986,762 $0.00
Bionano Genomics Inc BNGO
Series B Preferred Stock · derivative
2018-08-23 Conversion 6,810,098 $0.00
Bionano Genomics Inc BNGO
Series D-1 Preferred Stock · derivative
2018-08-23 Conversion 27,328 $0.00
Bionano Genomics Inc BNGO
Series B-1 Preferred Stock · derivative
2018-08-23 Conversion 22,161 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com